Gujarat Inject Intrinsic Value
GUJINJEC Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹11.85 | ₹9.48 - ₹14.22 | -70.0% | EPS: ₹0.30, Sector P/E: 22x |
| Book Value Method | asset | ₹13.33 | ₹12.00 - ₹14.66 | -66.3% | Book Value/Share: ₹6.67, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹16.00 | ₹14.40 - ₹17.60 | -59.5% | Revenue/Share: ₹8.00, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹15.80 | ₹14.22 - ₹17.38 | -60.0% | EBITDA: ₹1.00Cr, EV/EBITDA: 10x |
| PEG Ratio Method | growth | ₹11.85 | ₹10.66 - ₹13.04 | -70.0% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹11.85 | ₹10.66 - ₹13.04 | -70.0% | Revenue Growth: 15.0%, Adj P/E: 16.1x |
| ROE Based Valuation | profitability | ₹19.75 | ₹17.78 - ₹21.73 | -50.0% | ROE: 10.0%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹11.85 | ₹10.66 - ₹13.04 | -70.0% | EPS: ₹0.30, BVPS: ₹6.67 |
Want to compare with current market value? Check GUJINJEC share price latest .
Valuation Comparison Chart
GUJINJEC Intrinsic Value Analysis
What is the intrinsic value of GUJINJEC?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Gujarat Inject (GUJINJEC) is ₹13.33 (median value). With the current market price of ₹39.51, this represents a -66.3% variance from our estimated fair value.
The valuation range spans from ₹11.85 to ₹19.75, indicating ₹11.85 - ₹19.75.
Is GUJINJEC undervalued or overvalued?
Based on our multi-method analysis, Gujarat Inject (GUJINJEC) appears to be trading above calculated value by approximately 66.3%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Debt to Equity Ratio | 1.20 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 10.0% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 4.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.00x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Gujarat Inject
Additional stock information and data for GUJINJEC
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2024 | ₹-6 Cr | ₹-6 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2020 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |